| Version | Summary | Created by | Modification | Content Size | Created at | Operation |
|---|---|---|---|---|---|---|
| 1 | Huanli Gao | -- | 185 | 2026-09-28 11:46:59 |
An antibiofilm agent is a chemical, biological, or material-based entity that inhibits the establishment of a bacterial biofilm, impairs its structural or physiological integrity, or promotes the removal or dispersal of an established biofilm. Its defining target is the biofilm mode of growth: a surface-associated, structured bacterial community embedded in a self-produced extracellular polymeric substance (EPS) matrix, rather than bacterial viability alone [1]. Antibiofilm activity may therefore involve interference with initial surface attachment, cell–cell aggregation, EPS synthesis or degradation, biofilm-specific regulatory pathways—including quorum-sensing-associated signaling—or the persistence and organization of cells within the biofilm [1][2].
The term encompasses agents that prevent biofilm formation and those that disrupt mature biofilms; these activities are related but experimentally and mechanistically distinct. An antibiofilm agent is not necessarily a conventional antibacterial agent: it may reduce biofilm biomass, architecture, adhesion, or matrix-mediated protection without directly killing bacteria, whereas an antimicrobial agent is defined primarily by inhibition of microbial growth or survival [2][3]. Conversely, an antibacterial compound may be termed antibiofilm only when it demonstrably acts against biofilm formation or established biofilm communities.